BioSpace News Archive

Business

Sarepta Therapeutics to Announce Third Quarter 2017 Financial Results and Recent Corporate Developments on October 25, 2017

Sarepta will report third quarter 2017 financial results after the Nasdaq Global Market closes on Wednesday, October 25, 2017.

October 16, 2017

·

1 min read

Business

Tetraphase Pharmaceuticals Appoints Kam Unninayar as Chief Financial Officer

Tetraphase Pharma today announced the appointment of Kamalam (Kam) Unninayar as Chief Financial Officer.

October 16, 2017

·

4 min read

Business

Aeglea BioTherapeutics Inks Clinical Collaboration with Merck

Aeglea and Merck will evaluate the combination of Aeglea’s AEB1102 with Merck’s anti-PD-1 therapy, KEYTRUDA for the treatment of patients with small cell lung cancer.

October 16, 2017

·

4 min read

Drug Development

Ovid Therapeutics Announces Positive Preclinical OV101 Data Demonstrating Behavioral Improvements in Fragile X Syndrome Model

Ovid announced new positive preclinical data on OV101 that shows normalization of behavioral abnormalities that resemble those seen in people with Fragile X syndrome.

October 16, 2017

·

6 min read

Allergan Release: U.S. District Court for the Eastern District of Texas Issues Adverse Trial Decision Concerning RESTASIS (Cyclosporine Ophthalmic Emulsion) 0.05% Patents

Allergan today acknowledged that the U.S. District Court for the Eastern District of Texas has issued an adverse trial decision finding that the four asserted patents covering RESTASIS (Cyclosporine Ophthalmic Emulsion) 0.05% are invalid.

October 16, 2017

·

3 min read

Biotech Bay

PacBio’s Recent Projects Highlight Success of SMRT Sequencing for Characterizing Structural Variation in Human Genomes

A series of publications and initiatives from the genomics community demonstrates the rapid adoption of Single Molecule, Real-Time Sequencing for discovering structural variants throughout the human genome

October 16, 2017

·

5 min read

Business

CMU Dean Ramayya Krishnan Elected to Top Leadership Spot at INFORMS

INFORMS announced today that Ramayya Krishnan, Ph.D., Dean of Carnegie Mellon University’s Heinz College of Information Systems and Public Policy, has been elected as the 25th President of the INFORMS Board of Directors.

October 16, 2017

·

4 min read

Policy

Novo Nordisk: FDA Posts Briefing Materials Prior To Advisory Committee Meeting for Semaglutide

Novo Nordisk announced that the FDA has published the briefing documents ahead of the Advisory Committee meeting to discuss the NDA for approval of semaglutide.

October 16, 2017

·

1 min read

Intellipharmaceutics Announces Closing of $4M Financing

Intellipharmaceutics announced today the closing of its previously announced registered direct offering consisting of 3,636,364 common shares at a price of US$1.10 per share for gross proceeds of approximately US$4 million.

October 16, 2017

·

11 min read

Ablynx’s Publication in Accordance With Article 14 of the Belgian Law of 2 May 2007 Regarding the Publication of Major Shareholdings (The “Transparency Law”)

Ablynx received a notification of shareholdings from Consonance CapMan GP LLC on 11 October 2017.

October 16, 2017

·

4 min read